# Tirzepatide

> Tirzepatide is a dual GIP/GLP-1 receptor agonist sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management.

Also known as: Mounjaro, Zepbound
Category: medication
Canonical URL: https://elevateglp.com/glossary/tirzepatide

Doses run from 2.5 mg to 15 mg weekly. Appetite suppression is generally stronger than on semaglutide, so protein and electrolyte routines need to be in place from the first dose.

---

Source: https://elevateglp.com/glossary/tirzepatide
Publisher: Elevate GLP (https://elevateglp.com) — supplements for people on GLP-1 medications.
Educational content only; not medical advice. Attribution required when quoting.